Patent Assignment
Reel/Frame 044288/0522
Assignment of Assignor's Interest
Recorded: 2017-12-04
Pages: 3
Assignee
SANGAMO THERAPEUTICS, INC.
501 CANAL BLVD., SUITE A100, RICHMOND, CALIFORNIA, 94804
Covered Property
(1)
Engineered Target Specific Nucleases
Patent:
10,975,393 →
Application:
15/685,580 →
Publication:
US 2018/0087072
PCT:
PCT/US2017/048409 ↗